The Barcelona Institute for Global Health (ISGlobal), a research centre supported by ”la Caixa”, and Farmamundi signed a collaboration agreement with the aim of disseminating the right to health and promoting research and international cooperation projects related to health care, access to essential medicines, and the roadmap of the United Nations’ 2030 Agenda for Sustainable Development.
With their signatures, the general director of ISGlobal, Antoni Plasència, and the president of Farmamundi, Ricard Troiano, established last Tuesday, July 2, an alliance between both institutions. This alliance will allow the launching of joint initiatives defending the right to health, in line with the Sustainable Development Goals, and that contribute to breaking the vicious circle of "poverty-disease". The agreement proposes carrying out joint activities in congresses, research days, and public health campaigns, among others.
For Leire Pajín, Director of Global Development at ISGlobal, "SDG 17 challenges us to generate alliances among governments, the private sector and civil society in order to ensure sustainable development." She emphasises that "the alliance with Farmamundi is part of this philosophy, with the aim of combining experiences and joining common visions and values that allow better access to health —sanitary systems, treatments and preventive policies— especially for the most disadvantaged people on the planet."
"It is a key partnership to further advance health cooperation and bring Farmamundi’s work closer to defending the right to health, by working hand in hand with an institution such as ISGlobal, whose progress in the fight against malaria, research in Chagas disease, parasitic diseases and viral and bacterial infections we follow closely", explains Ricard Troiano. Proof of this is the Research Prize that Farmamundi, on occasion of its 25th anniversary, awarded to ISGlobal in October 2018.